Preferred Drug List (PDL) Updates
PO Box 733
Elk Grove Village, IL 60009-0733
April 9, 2021
Dear YouthCare Provider,
This is an important message from YouthCare HealthChoice Illinois.
YouthCare would like to inform you that the coverage of Metformin Hydrochloride ER Modified Release (GLUMETZA) and Metformin Hydrochloride ER Osmotic (FORTAMET) is changing on May 15, 2021 for all members. Effective May 15, 2021, this medication will be removed from the formulary. Please reference the table below for information regarding medication changes and alternative preferred agents.
YouthCare would like to work with you to help transition the impacted members onto a preferred formulary alternative. If a member requires continued therapy for a medication that has been changed, please submit a prior authorization with appropriate clinical documentation. Prior authorizations can be submitted by faxing 844-989-0154.
Impacted Medication |
Medication Change |
Preferred agents |
|---|---|---|
Metformin Hydrochloride ER Modified Release (GLUMETZA ®) |
Non-preferred after 5/15/21 |
|
Metformin Hydrochloride ER Osmotic (FORTAMET ®) |
Non-preferred after 5/15/21 |
|
Note: Active prior authorizations for this medication will not be affected.
If you have any questions, please call YouthCare Provider Services at 844-289-2264.
Sincerely,
YouthCare
May 15, 2021
Dear Provider,
This is an important message from YouthCare HealthChoice Illinois.
YouthCare would like to inform you that the coverage of long acting antipsychotic injectables (Abilify Maintena ®, Aristada ®, Aristada Initio ®, Invega Sustenna ®, and Invega Trinza ®) is changing on June 15, 2021 for all members. Effective June 15, 2021, these medications will be preffered with a prior authorization. Please reference the table below for information regarding medication changes and alternative preferred agents.
YouthCare would like to work with you to help transition the impacted members onto a preferred formulary alternative. If a member requires continued therapy for a medication that has been changed, please submit a prior authorization with appropriate clinical documentation. Prior authorizations can be submitted by faxing 844-989-0154.
Impacted Medication |
Medication Change |
Abilify Maintena ® |
Preferred with prior authorization after 6/15/2021 |
Aristada ® |
Preferred with prior authorization after 6/15/2021 |
Aristada Initio ® |
Preferred with prior authorization after 6/15/2021 |
Invega Sustenna ® |
Preferred with prior authorization after 6/15/2021 |
Invega Trinza ® |
Preferred with prior authorization after 6/15/2021 |
Note: Active prior authorizations for this medication will not be affected.
If you have any questions, please call YouthCare Provider Services at 844-289-2264.
Sincerely,
YouthCare